Hakariya H - Search Results

1

A trial of structured debate as a self-learning method for students and young healthcare providers to discuss social issues in general and family medicine: A case report in Japan.

Ikejiri T, Lee J, Yokoyama N, Hakariya A, Otsuka Y, Hakariya H. Ikejiri T, et al. Among authors: hakariya h. J Gen Fam Med. 2024 May 27;25(5):293-294. doi: 10.1002/jgf2.706. eCollection 2024 Sep. J Gen Fam Med. 2024. PMID: 39574556 Free PMC article.

2

Addressing Vaccine Hesitancy and misinformation amidst Japan's self-amplifying mRNA COVID-19 Vaccine Rollout.

Hakariya H, Ohashi R. Hakariya H, et al. QJM. 2024 Nov 5:hcae214. doi: 10.1093/qjmed/hcae214. Online ahead of print. QJM. 2024. PMID: 39499164

3

Prestigious Japanese biomedical awards need to become more gender-representative.

Hakariya H. Hakariya H. Nature. 2024 Oct;634(8036):1053. doi: 10.1038/d41586-024-03519-7. Nature. 2024. PMID: 39472537 No abstract available.

4

Gender disparities among prestigious biomedical award recipients in Japan: A cross sectional study.

Hakariya H, Ikejiri T, Hakariya A, Hara M. Hakariya H, et al. Health Sci Rep. 2024 Sep 18;7(9):e70074. doi: 10.1002/hsr2.70074. eCollection 2024 Sep. Health Sci Rep. 2024. PMID: 39301113 Free PMC article. No abstract available.

5

Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals.

Hakariya H, Moriarty F, Ozaki A, Mulinari S, Saito H, Tanimoto T. Hakariya H, et al. Clin Transl Sci. 2024 Jul;17(7):e13879. doi: 10.1111/cts.13879. Clin Transl Sci. 2024. PMID: 38987923 Free PMC article.

6

Intracellular Delivery of Antisense Oligonucleotides by Tri-Branched Cyclic Disulfide Units.

Lyu F, Hakariya H, Hiraoka H, Li Z, Matsubara N, Soo Y, Hashiya F, Abe N, Shu Z, Nakamoto K, Kimura Y, Abe H. Lyu F, et al. Among authors: hakariya h. ChemMedChem. 2024 Oct 16;19(20):e202400472. doi: 10.1002/cmdc.202400472. Epub 2024 Aug 27. ChemMedChem. 2024. PMID: 38957922

7

Evaluating time to withdrawal of anti-Cancer drug indications that received FDA's accelerated approval.

Hakariya H, Ozaki A, Mulinari S, Moriarty F, Tanimoto T. Hakariya H, et al. QJM. 2024 Jun 12:hcae115. doi: 10.1093/qjmed/hcae115. Online ahead of print. QJM. 2024. PMID: 38867701 No abstract available.

8

Illicit Trade of Prescription Medications Through X (Formerly Twitter) in Japan: Cross-Sectional Study.

Hakariya H, Yokoyama N, Lee J, Hakariya A, Ikejiri T. Hakariya H, et al. JMIR Form Res. 2024 May 28;8:e54023. doi: 10.2196/54023. JMIR Form Res. 2024. PMID: 38805262 Free PMC article.

9

The Beni-Koji scandal and Japan's unique health food system.

Hashimoto T, Ozaki A, Hakariya H, Takahashi K, Tanimoto T. Hashimoto T, et al. Among authors: hakariya h. Lancet. 2024 May 25;403(10441):2287-2288. doi: 10.1016/S0140-6736(24)00882-1. Lancet. 2024. PMID: 38796200 No abstract available.

10

Japan initiates market authorization of weight-loss drug semaglutide under universal health coverage, but with stringent prescription restrictions.

Hakariya H, Ohnishi M, Tanimoto T. Hakariya H, et al. Diabetes Obes Metab. 2024 Aug;26(8):3006-3008. doi: 10.1111/dom.15638. Epub 2024 May 15. Diabetes Obes Metab. 2024. PMID: 38747140 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters